Skip to content

Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy

Effects of Gut Microflora on the Immune and Nutritional Status of CRC Patients After Chemotherapy

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02169388
Enrollment
30
Registered
2014-06-23
Start date
2014-06-30
Completion date
2015-01-31
Last updated
2014-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Effects of Chemotherapy, Gastrointestinal Neoplasms, Malnutrition, Tumor Immunity

Keywords

Gut microflora, colorectal cancer, Chemotherapy, Immunity, Nutrition

Brief summary

Probiotics modulate the gut microflora and immune status in CRC,which can reduce the side effects of chemotherapy such as diarrhea,infection,neutropenia etc.

Detailed description

Chemotherapy destroys the intestinal mucosal barrier, affects intestinal flora, causing bacterial translocation, infection and other complications; Probiotics may restore the intestinal immunity, mucosal barrier, and nutrient absorption.The adverse effects of chemotherapy and the malnutrition status may be relieved via probiotic administration.

Interventions

DRUGProbiotic

Microbial composition using probiotic

DRUGplacebo(for probiotic)

microbiota modulation using placebo

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled for chemotherapy after radical resection of colorectal cancer

Exclusion criteria

* Palliative resection of colorectal cancer * Antibiotic,probiotic or prebiotic usage within 1months * Other malignancy * History of other abdominal surgery * Coagulopathy or bleeding disorders * Pregnant or breast-feeding(for females) * Impaired liver or renal function

Design outcomes

Primary

MeasureTime frameDescription
Composition of Microorganisms in stool after probiotic intervention5 monthsPrimary coordination of fecal samples' 16s rDNA (ribosomal DNA) will be compared between two Groups using Braycurtis distance based Primary coordination analysis (PCoA).
Short-chain fatty acids in feces of patients after chemotherapy5 monthsThe total concentration of Short-chain fatty acids in the in feces of patients after chemotherapy.
Frequency and severity of Adverse effects during Chemotherapy5 monthsAdverse effects includes vomiting, nausea, diarrhea and abdominal pain.

Secondary

MeasureTime frameDescription
The observed changes in immune status after chemotherapy5 monthImmune status indexes include percentage of Neutrophils, total lymphocytes, lymphocyte subgroups, plasma immunoglobulin level, CRP (C reactive protein).
The observed changes in nutritional status after chemotherapy5 monthsNutritional status indexes include BMI, percentage of body weight changes, plasma albumin and prealbumin.

Countries

China

Contacts

Primary ContactYanqing Li, MD.PhD.
liyanqing@sdu.edu.cn86-531-82169236

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026